These MMP19+ TAMs form a ring-shaped barrier structure surrounding the cancer cells, thereby inhibiting the infiltration of CD8+ T cells into the tumor interior and ultimately contributing to the resistance of LC-BoM to immunotherapy. The gene discussed is CD8A; the disease is cancer.